Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 518-524

  Zhao, Bo ^a   Jin, Ning Yi ^a,b   Wang, Rui Lin ^b   Zhang, Li Shu ^b   Zhang, Ying Jiu ^a,b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; PLASMID DNA; VIRUS SPIKE PROTEIN;

ANIMAL CELL; ANTIBODY TITER; ANTIGEN SPECIFICITY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENBANK; GENETIC RECOMBINATION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOSTIMULATION; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; SARS CORONAVIRUS; SPLEEN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CRICETINAE; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

SARS CORONAVIRUS;

EID: 33750944790     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.518     Document Type: Conference Paper

References (23)

1. Ahlers JD, Takeshita T, Pendleton CD, et al.: Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence. Proc. Natl. Acad. Sci. U.S.A. 1997;94:10856-10861.
2. Alexander J, del Guercio MF, Maewal A, et al.: Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J. Immunol. 2000;164:1625-1633.
3. Alexander J, Sidney J, South wood S, et al.: Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1994;1:751-761.
4. de Groot AS: How the SARS vaccine effort can learn from HIV-speeding towards the future: Learning from the past. Vaccine 2003;21:4095-4101.
5. Armstrong J, Niemann H, Smeekens S, et al.: Sequence and topology of a model intracellular membrane protein, El glycoprotein, from a coronavirus. Nature 1984;308:751-752.
6. Black JG, and Lawson KF: The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Can. J. Comp. Med. 1980;44:169-176
7. Fleming JQ, Shubin RA, Sussman MA, et al.: Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protein mice from encephalitis. Virology 1989;168:162-167.
8. Jiang SB, He YX, and Liu SW: SARS vaccine development. Emerging Infect. Dis. 2005;11:1016-1020.
9. Chow KY, Hon CC, Hui RK, et al.: Molecular advances in severe acute respiratory syndrome-associated coronavirus. Genomics Proteomics Bioinformatics 2003;1:247-262.
10. Krokhin O, Andonov A, Feidmann H, et al.: Mass spectrometric characterization of proteins from the SARS virus. Mol. Cell. Proteomics 2003;2:346-356.
11. Lai MM, and Cavanagh D: The molecular biology of coronaviruses. Adv. Virus Res. 1997;48:1-100.
12. Li JX, Luo CQ, Deng YJ, et al.: The structural characterization and antigenicity of the S protein of SARS-CoV. Genomics Proteomics Bioinformatics 2003;1:108-129.
13. Ito N, Sugiyama M, Yamada K, et al.: Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain. Microbiol. Immunol. 2005;49:971-979.
14. Panina-Bordignon P, Tan A, Termijtelen A, et al.: Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 1989;19:2237-2242.
15. Peiris JS, Lai ST, Poon LL, et al.: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;36:1319-1325.
16. Rota PA, Oberste MS, Monroe SS, et al.: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1399.
17. Stadler K, Masignani V, Eickmann M, et al.: SARS: Beginning to understand a new virus. Nat. Rev. Microbiol. 2003;1:209-218.
18. Wang ZJ, Yuan ZH, Matsumoto M, et al.: Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem. Biophys. Res. Commun. 2005;327:130-135.
19. World Health Organization: Japanese encephalitis vaccines. Wkly. Epidemiol. Rec. 1998;73:334-344.
20. Yang ZY, Wing PK, Yue H, et al.: A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561-564.
21. Zeng FY, Chow KY, Hon CC, et al.: Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochem. Biophys. Res. Commun. 2004;315:1134-1139.
22. Zhao P, Cao J, Zhao LJ, et al.: Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. Virology 2005;331:128-135.
23. Zhu MS: SARS immunity and vaccination. Cell. Mol. Immunol. 2004;1:193-198.